Researchers have initiated a new clinical trial to determine the optimal dose and safety of T regulatory cells (T-regs) to decrease the risk of immune reactions common in patients undergoing blood and marrow transplantation. The therapy may lead to a future treatment for diabetes and other autoimmune diseases.
First Clinical Trial Using T-reg Cells From Cord Blood In Leukemia Treatment In US Begins
- ScienceDaily
- 5. 9 2007 (06:00)